In continuation of the successful past scientific meetings in Budapest, Paris, Berlin, Florence, Geneva and Barcelona, the 7th World Meeting on Pharmaceutics, Biopharmaceutics andPharmaceutical Technology will be held in Malta in 2010.

In 2010, special emphasis will be placed on industrial related topics. So the meeting will help bridging the gap between fundamental academic research and industrial applications,offering the opportunity to initiate fruitful cooperation between university and industry.
more

The World CRO Summit China 2010 will provide the most updated information from local and foreign practitioners concerning trends and regulatory updates in the CROs, pharmaceuticals and biotechnology industry. Delegates will also get to hear from experts on how to navigate successfully in China's regulatory landscape and as well as innovations in the CRO space. more

10% discount for SBA members.

Helping you to rapidly fill the gaps to reach a state of competence and learning autonomy is what our 3 day intensive course is all about.

Day 1 is devoted to demystifying doping and anti-doping sciences and building a simplified “toolbox” to explore the entire field of doping/anti-doping.
Day 2 is spent applying the tools acquired in day 1 to the WADA prohibited list to generate an anti-doping decision-making tree.
Day 3 integrates the newly acquired knowledge by analyzing real life case studies from a simple, but scientifically rigorous point of view to better address major challenges in the fight against doping today and tomorrow. more

This course focuses on developing and implementing regulated computer systems with an appropriate level of documented evidence to satisfy FDA expectations. more

Join us in the Swiss Pavilion!

Biologic Manufacturing World Asia will bring together international and regional biopharmaceutical manufacturers, small biotechs, academic institutions, contract manufacturing service and technology providers to discuss trends, best offshoring, outsourcing and operational strategies for biologic manufacturing, methodologies and technologies to improve productivity, quality, efficiency and profitability.
more

Join us in the Swiss Pavilion!

World Pharma Trials Asia is an event convening pharmas, biotechs, and CROs to explore offshoring & outsourcing opportunities in Asia for cost effective preclinical and clinical drug development, at a time where Asia’s CRO market is growing at a doubling rate yearly, with more and more global pharma and biotechs are offshoring and outsourcing their drug development to Asia.
more

Join us in the Swiss Pavilion!

Drug Discovery Technology World Asia 2010 is where leading scientists come to find solutions, ideas, collaborations and opportunities to connect with pharma, biotech R&D colleagues. If you are in the business of providing world-class products and solutions to life science research and drug discovery sector, you need to be here.
more

Join us in the Swiss Pavilion!

Pharma R&D Partnering World Asia 2010 will bring together international and regional pharmaceutical companies, start-up & spin-off biotechs, research and academic institutions, professional investors, contract research service providers to network and evaluate partnering opportunities in Asia. more

15% discount for SBA members.

Through a series of presentations and interactive discussions covering key issues such as current market trends, biobetters, the global regulatory environment, pricing and reimbursement strategies and biosimilars in emerging markets, participants will gain new insight and share hands-on experiences with leading companies in the pharma and biotech industry. more

Join us in the Swiss Biotech Paviliion!

Good business starts with good knowledge about the market and good relationship with key decision makers, and we understand that. With more mergers and acquisitions happening in the industry, more new players coming into the market place, Biopharma industry has never been evolving so rapidly and new relationships need to built, and we understand that too.

With that, Terrapinn put together BioPharma Asia Convention in 2010, uniquely positioned as Asia’s only exhibition that showcases leading technocrats, solution and service suppliers across the entire value chain of the biopharma industry in Asia. more

3rd SwAPP Experts Exchange Expertise Meeting on:

• Non-interventional clinical trials
• panel discussion on non-interventional and interventional clinical trial
• Workshop Regulatory: Implementation of eCTD at Swissmedic

This small conference is intended especially to attract people employing enzymes in organic chemistry as well as people from closely connected disciplines. The conference is the public part of the kick-off meeting for a Marie-Curie Network (BioTrains) initiated and headed by Nick Turner (Manchester/UK). The lectures will give an overview about the current front-running research in biocatalysis conducted in the various groups within as well as outside the BioTrains network.
I am looking forward to discussing with you various aspects of biocatalysis in Graz. more

analytica 2010 will present products and innovations in the analysis, laboratory- technology and biotechnology sectors with the usual high level of quality. As always, several manufacturers will use this attractive platform to introduce new products that are ready for market. Everything at the fair revolves around the laboratory: analytica showcases the entire value-added chain for laboratory technology, analysis and quality control, measuring and testing technology, biotechnology, the life sciences and diagnostics. The fact that analytica is such a high-level exhibition is in part due to the support that it receives from our renowned German and international partners. more

Die Freuden und Leiden der jungen Unternehmen

• Impulsreferate von erfolgreichen Startups: bisherige Entwicklung, Erfolgsgeheimnisse, Tipps und Tricks
• Paneldiskussion: «Wie realisiere ich meinen Traum?»
  Diskussionsteilnehmer/innen: Unternehmer/innen, Vertreter/in Technologietransfer und Vertreter/in Universität
• Support durch venturelab und nächste Schritte: Startup-Training, Tools, Anlaufstellen: Wo finde ich Investoren und wie organisiere ich das Startkapital?

10% discount for SBA members.

Helping you to rapidly fill the gaps to reach a state of competence and learning autonomy is what our 3 day intensive course is all about.

Day 1 is devoted to demystifying doping and anti-doping sciences and building a simplified “toolbox” to explore the entire field of doping/anti-doping.
Day 2 is spent applying the tools acquired in day 1 to the WADA prohibited list to generate an anti-doping decision-making tree.
Day 3 integrates the newly acquired knowledge by analyzing real life case studies from a simple, but scientifically rigorous point of view to better address major challenges in the fight against doping today and tomorrow. more

A Fresh Perspective For A New Decade

Now in its fourth year, BioFinance and BioInnovate Europe continues to be a leading event in the biotech sector. Attracting over 250 delegates from across the sector, this one day conference will be packed with presentations and panel discussions from financial experts and a focus on innovation in the new decade.

As the first quarter of 2010 draws to a close, the BIA’s annual BioFinance and BioInnovate Europe conference will be looking at assessing the ways in which the biotechnology sector can flourish in the new environment and in the new decade. With its focus on two of the key challenges for companies – access to finance and access to innovation – the day will highlight the new mechanisms and ways of working that are on the horizon, many of them born out of adversity. more

Launch of the first SBA Nanotech Platform Exchange Meeting in cooperation with IBM.

The interactions between life sciences and nanotechnology will be featured in a series of platform exchange meetings - starting with an overview followed by more specific topics such as e.g. "lab on a chip" and "nanoparticles". more

25% discount off full conference fee for SBA members.

IBC's China Pharmaceutical R&D Summit has emerged as one of the leading high-level pharmaceutical business conferences in China, with attendance and participation of over 300 very senior executives from many top tier companies including Roche, Eli Lilly, Merck, AstraZeneca, GSK among others.

The 2010 event aim to raise the stakes by bringing together not only senior industry executives, but also top academia, government agencies, NGOs, as well as key opinion leaders from different countries and industries to share their experiences and strategies, particularly in the areas of innovation, leadership and global vision. more

10% discount for SBA members.

The Red Biotech course will cover the same basic science, focusing on medical and pharmaceutical applications.

Day 1 is devoted to road-mapping the entire field of molecular biology and understanding how biologists think and what lies at the heart of this science.

Day 2 is spent exploring short cases illustrating all of the important features of molecular biology. We reveal the common processes and unifying principles underlying many agricultural, medical, pharmaceutical and industrial biological techniques. more

The course provides a thorough understanding of the activities involved during the Phase 1 and 2 stages of Drug Development. more

Following the success of the first three editions of the NP2D (“Natural Peptides to Drugs”) congress, it was an obvious decision to organise a fourth edition of NP2D. This will take place from 11 to 14 April 2010 in Zermatt again, at the foot of the majestic Matterhorn mountain in the heart of the Swiss Alps. NP2D is devoted to the development and commercialisation of peptide-based drugs and we are pleased to invite you to attend this unconventional event!

NP2D has been established as an international, interdisciplinary exchange platform for specialists and decision makers involved in major overlapping areas of Pharma R&D such as Peptidic hormones, Antimicrobial peptides, Toxins, Immunomodulators and more . more

10% discount for SBA members.

Process changes made during the manufacture of recombinant proteins can have profound implications on the quality, safety, efficacy and regulatory approval of your product.

This 2-day course gives you a practical insight into how to manage process change so as to ensure regulatory compliance and product consistency at all times. With more than 20 industry case studies to work on, this course is your ultimate guide to finding the best ways to satisfy the needs of the regulators and understand how various process changes may impact the success of your product. more

50£ discount on registration fee for SBA members.

Call for Swiss life science companies interested in forging stronger UK-Swiss bioindustry trade links, scientific collaborations, partnerships and strategic alliances…

BioTrinity 2010 is UK's Premier Biopartnering and Investment conference and is building on its reputation as Europe's fastest growing partnering conference with more investors than any other UK conference.

Join us as we bring together a critical mass: a multitude of investors, global pharma and innovative R&D companies all within an hour of Heathrow. 35 investment firms have already confirmed participation with 3 months to go.

more

The course provides a thorough understanding of the activities involved during Phase 3 and 4 of Drug Development. more

Upon completion of this course you will have a clear understanding of international regulatory authority regulations and expectations and will have gained the background knowledge necessary to effectively plan and execute QC test method validation programs. more

Course notes and interactive exercises address how to write effective correspondence and reports in support of the company’s activities. You will learn how to organize and deliver information for the intended audience. more

For SBA members by invitation only.

For the third time, the Assembly General of the Swiss Biotech Association will be part of the 3rd Swiss Equity Biotech Day at the SIX Swiss Exchange, Convention Point in Zurich.

Participants of the Assembly General have free access to the Swiss Equity biotech day.
more

The Leading Swiss Biotech Conference and Annual General Assembly of the Swiss Biotech Association

For the third, Swiss Equity magazine organizes the Swiss Equity biotech day in co-operation with the Swiss Biotech Association and SIX Swiss Exchange. This unique get-together of the Swiss biotech industry includes presentations by listed and privately-held companies, as well as expert views on current business and science trends.
more

Context: Managing and carrying out clinical trials, while respecting the legislative framework and good practices management. Dealing with regulations applying to medical devices and therapeutics.

Objectives: To develop understanding and competencies in the clinical trial process, in the regulations framework including the needed authorizations and approvals for medicines and devices. more

The Exeter Biocatalysis Centre is a Multidisciplinary Centre that has been established to study the structure, mechanism and commercial application of enzymes - 'Natures Catalysts' and is organizing this conference on Novel Enyzmes. more

Insights and practical suggestions on how to develop and manage a clinical phase-dependent CMC regulatory compliance strategy for biopharmaceuticals and biologics are offered in this course. more

10% discount for SBA members.

Helping you to rapidly fill the gaps to reach a state of competence and learning autonomy is what our 3 day intensive course is all about.

Day 1 is devoted to demystifying doping and anti-doping sciences and building a simplified “toolbox” to explore the entire field of doping/anti-doping.
Day 2 is spent applying the tools acquired in day 1 to the WADA prohibited list to generate an anti-doping decision-making tree.
Day 3 integrates the newly acquired knowledge by analyzing real life case studies from a simple, but scientifically rigorous point of view to better address major challenges in the fight against doping today and tomorrow. more

This course presents a comprehensive overview of process writing that the binding regulations require. more

This course will provide the participant with knowledge of current GMPs, how they are applied in the Bio/Pharmaceutical market today, and how they will be enforced in the future. more

In this course QA/QC regulations and guidances from the U.S. FDA, EMEA and ICH are discussed in detail. more

This course addresses what documents you need to control, what documentation you need to support your actual system and how to keep your documents current and compliant. more

Europe’s largest biopharmaceutical trade fair, will co-locate with INTERPHEX in 2010 to create the most comprehensive annual gathering in the Life Sciences industry.

BIOTECHNICA America focuses on the tools and technologies in Phases I-III clinical trials and existing commercial operations from drug development to manufacturing.
more

INTERPHEX is the world’s most trusted source for leading- edge technology, education, and sourcing of the products and services that drive scientific innovation for Life Sciences manufacturing, from drug development to market – accelerating regulated products for patient care globally.

INTERPHEX is the only Life Sciences event that represents a true crosssection of the pharmaceutical and  biopharmaceutical industries. Industry-leading professionals worldwide make INTERPHEX the industry’s annual focal point for driving change and efficiencies for the global pharmaceutical and biopharmaceutical market. more

Since its debut in 2002, the annual Bio-IT World Conference & Expo has established itself as the premier event showcasing the myriad applications of IT and informatics to biomedical research and the drug discovery enterprise. The 2010 program features compelling talks from industry and academia on new trends in data generation, knowledge management, and information technology in life sciences and drug development, including best practice case studies and joint partner presentations relevant to the technologies, research, and regulatory issues of life science, pharmaceutical, clinical and IT professionals. One new feature is splitting the previous Track "IT Infrastructure & Operations" into two to cover hardware and software issues in more depth.
more

10% discount for SBA members.

Transform the effectiveness of your therapeutics proteins

Stripped of tired case studies and presentations on the latest company share price, the Biorbis Advancing Protein Therapeutics event will focus on robust science, and address high opportunity areas and challenges around developing better protein drugs. more

The groundbreaking and innovative content will span a diverse range from immunological intervention to stem cell and other reparative therapies, focusing on how we can move medical research closer to commercially-ready medical technology.

This one and a half day event is the perfect forum in which to explore research, ideas, and cutting-edge breakthroughs and to build and broker relationships with like minded professionals.

more

This course is intended to give participants a thorough overview and practical understanding of Current Good Manufacturing Practices for laboratory compliance. more

Upon completion of this course attendees will have a thorough knowledge of the requirements for developing and marketing Medical Devices in the European Union. more

This course provides an overview of how to present product information clearly and concisely for the targeted audience. Hands-on exercises reinforce the course content. more

Die Veranstaltung setzt sich mit verschiedenen Themen und Aspekten der Zulassung pflanzlicher Arzneimittel heute und in naher Zukunft auseinandersetzen. Über die Grenzen zu gehen ist das Ziel der zahlreichen Bemühungen, Monographien zu erstellen. Eine ganze Reihe von Monographien sind auch schon publiziert und gültig. Wie entstehen diese Monographien? Wie verbindlich sind sie? Wie viel nationalen Freiraum lassen solche Monographien in Deutschland und Österreich, was für eine Bedeutung erhofft man sich in der Schweiz, die im HMPC nicht vertreten ist? more

25% discount off full conference fee for SBA members.

TIDES® remains THE place to meet all the important players in oligonucleotide and peptide therapeutics and diagnostic development and manufacturing, as well as raw material and equipment supply - and now discovery too. more

25% discount off full conference fee for SBA members.

New for 2010, IBC is co-locating its 2nd annual Oligonucleotide Therapeutics Discovery conference with TIDES 2010 in Boston.

This exciting conference will discuss strategies for chemically modifying, optimizing and selecting oligonucleotides in a preclinical setting and provide numerous case studies of oligonucleotide projects moving through discovery, preclinical and beyond. more

This course focuses on understanding the requirements of the new EU Clinical Trial Directive and the issues inherent in any new regulatory process. more

The course will provide the tools needed to prepare for a Clinical Data System inspection and to assess risk areas that need prioritization. more

Context: Valuation of new ventures requires assessments of a several dimensions, such as uniqueness and potential of the innovations associated with the venture, competitive positioning, management team, etc.

Objectives: To be exposed to state of the art methods for assessing the valuation of new ventures, in the medtech/biotech domain. more

10% discount for SBA members.

Vaccine Innovation will address how big pharmaceutical and leading vaccine biotech companies are developing better vaccines and delivering them to patients. The focus is on providing knowledge and contacts that will significantly increase the quality of your vaccine R&D and the performance of your business.
more

The course will cover topics relating to pre-clinical and clinical requirements, as well as, addressing the structure of the regulatory agencies in the EU and individual European countries. more

This event for SME and other private sector participants will present the necessary legal and financial information for the proposal preparation on the one hand (morning session) as well as the negotiation and project management phases (afternoon session) of FP7 projects on the other.

In addition, successful FP participants from the private sector will share their experiences with you and give you helpful tips whether you are a researcher or a financial officer with the aim to improve your knowledge of FP7 rules. more

Join the Swiss Pavilion organized by Swiss Biotech and OSEC

The 2010 BIO International Convention, May 3-6, 2010 is the global event for biotechnology that hosts more than 125 sessions, an exhibition with more than 1,800 companies and 60 pavilions and a business forum with 14,000 One-on-One partnering sessions. With nearly 60 countries represented, the attendees are a blend of international and domestic executives and management from research, business, and academic and investment communities.

The event works toward expanding the biotech innovations that help heal, fuel and feed the world.


more

The 2010 SSB Annual Meeting and General Assembly will take place at the Empa Academy in Dübendorf on May 5, 2010.

The topic of the meeting will be Biomaterials and Tissue Engineering. more

Inhalt
Die Teilnehmenden erhalten vertiefte Kenntnisse zum Thema Laufbahn und Karriere und Anhaltspunkte, wie sie diese individuell gestalten können. Es werden die vier typischen Phasen der Problemlösung in der Laufbahn Entwicklung bearbeitet:
* Analyse und Zielformulierung
* Lösungswege und Alternativen
* Bewerten und Entscheiden
* Durchsetzen und Realisieren
Generelle Hinweise zum Bewerbungsprozess mit Inserat, Blindbewerbung und Personalvermittlung - Bewerbungsschreiben - Bewerbungsgespräch - Assessment

Teilnehmerkreis
Chemiker und sonstige Naturwissenschaftler, die sich mit der Frage "wo bewerbe ich mich, warum und wie?" auseinander setzen wollen. more

Was erwartet ein Journalist von mir? Wie formuliere ich meine Botschaft? Wie bereite ich mich auf ein Interview vor? Habe ich das Recht, den Artikel vor der Publikation zu lesen?

Im Umgang mit Journalisten gelten ganz bestimmte Spielregeln. Wer mit diesen vertraut ist, dem wird es leichter fallen, mit den Medien zu sprechen und sich so in der Öffentlichkeit Gehör zu verschaffen.
more

Welcome to the 3rd European Conference for Clinical Nanomedicine. We look forward to meet the Nanomedicine Community in Basel We have already many Paper-and Poster- submissions and look forward to many more!
Oral sessions will include:

• Sessions on the following clinical topics: Nanomedicine for cardiovascular disease, oncology, haematology, neurology / neurosurgery, implants, inflammation, orphan diseases, dermatology, eye disease, ear disease, tissue repair, orthopaedics and many others.
• Technology sessions, including nano-systems, nanoparticles, nanoanalytics and diagnostics, toxicology, nanoimaging, targeted drug delivery using nanoparticles, GMP and quality assurance, and others…
• Sessions focusing on the implications of Nanomedicine for society, developing countries, the environment public health finance and other subjects.
• Sessions describing in detail unsolved medical problems for which a novel solution is proposed.
• Sessions proposing novel hypotheses, concepts and ideas, if they can be supported by thorough reasoning.

25% discount off full conference fee for SBA members.

IBC's Biological Assay conference will give you the tools you need to quickly and efficiently develop critical biological assays needed for successful product development. This is the only conference with no hidden agenda, and no single point of view being pushed. It is a technical conference which allows you to discuss and share information in a collegial environment. Here you will discover many practical approaches that can be applied to your assays. Plate layouts, new cell cultivation techniques, statistical tools for validation and assay development, use of platform approaches are just some of the new topics you will hear at this year's conference. more

• one price includes access to all 9 programs
• NEW Biotherapeutic Targest & Bispecific Antibodies programs
• over 1000 participants
• 170 scientific presentations

After completion of this course the attendee will have a strong understanding of the principles and practices of Project Management. more

Context: Manufacturing facilities occupy a growing share of an enterprise’s strategic horizon. Planning, design, construction, qualification, validation & operation are key steps to deliver a bio-pharmaceutical facility.

Objectives: To address aspects associated with operation & manufacturing, such as risk based management, quality systems, GMP and their impact on biopharmaceutical process validation. more

10% discount on conference fees for SBA members.

Europe’s BioProcess International has become the largest, most well respected forum focusing solely on technical, regulatory and strategic planning challenges in the manufacture of biotherapeutics. Providing you with the platform to enhance your bioprocessing strategies, it will help you find the solutions to keep your company competitive and build on your existing knowledge base.

5 conferences, 1 event:

• Formulation Strategies for Biologics
• Recovery and Purification
• Cell Culture and Upstream Processing
• Analytical Methods for Biologics
• Scaling-up, Economics and Manufacturing Strategies

BioEquity is the leading venue for public and private biotech investors throughout Europe. Together, BioCentury Publications, EBD Group and BIO will be producing the 11th edition of this annual international conference in 2010 in Zurich. more

The primary objective of this course is to develop an understanding of the principles and techniques involved in the practice of Root Cause Analysis. more

The objective of this course is to provide an overview of the preparation, design and management aspects of clinical trials for medical devices. more

This course is specifically focused on the law, regulations and policies set down by the FDA for the manufacture of medical devices. more

15% discount for SBA members.

PAT and QbD techniques are now well established within the small molecules field and the focus has shifted to incorporate application within the biopharmaceuticals arena. With key regulatory bodies including the FDA and EMEA actively involved in pilot schemes, more than ever it is imperative to ensure you have the correct application strategy. This event brings together professionals specifically tasked with implementing PAT and QbD tools and techniques specifically within the Bioprocess and Bioproduction area delivering a unique opportunity to hear from other leading biopharmaceutical companies and discuss the key challenges that are currently being faced and devise new solutions. more

The purpose of this course is to provide an introduction to the fundamentals of process validation, explaining how, when, where and why you should validate. more

20% Discount for switt and SBA members.

Aims
The aims of the course are to:

• Give you a structured approach to prepare for negotiations
• Remove any weaknesses in your negotiating style
• Enable you to negotiate effectively with different cultures
  

Bangalore Bio is now Bangalore Bio India.

The 10th edition of the event will comprise of Multi-track Conference, Exhibition, BioPartnering and networking events to meet your business objectives.

This event is now recognized as the Gateway to India generating tremendous interest and response worldwide from leading Bio Nations like USA, Canada, UK, France, Germany, Spain, Australia, New Zealand, Cuba, South Africa, Japan, Singapore, China and Korea. more

20% Discount for switt and SBA members.

Aims
The aims of the course are to:

• Give you a structured approach to prepare for negotiations
• Remove any weaknesses in your negotiating style
• Enable you to negotiate effectively with different cultures
  

This is a one-week comprehensive course aimed to promote entrepreneurship in the fi eld of Biotechnology. It provides an in-depth understanding of what it takes to set up and fi nance successful biotechnology companies in Europe.
Extensive discussions and case studies will emphasize the challenging issues that are critical to this relatively new market opportunity.

During the week, participants may draft a plan for developing a new opportunity in their area. Participants will be given guidance on how to take on leadership roles in their communities, to start and fund their own business, or play a more active role in investing in life-sciences ventures. more

The conference focuses on three main topics:

• The integration of disposable devices in biopharmaceutical manufacturing
• New disposable technology for biopharmaceutical manufacturing
• Networking and technical platforms for single-use component manufacturers,systems integrators, contract manufacturers, end-use biopharmaceuticalresearchers, manufacturers and regulators
  

Context: The development of new products/devices/medicines is a very long process. A thorough planning of the different steps/milestones of the project is key for a long term success.

Objectives: To assess the key success factors for a project and to master its planning. To learn how to give a project solid foundations and precise objectives; to address project risk management. more

10% discount for SBA members.

Improve viral detection and removal methods, build an effective risk management plan and keep ahead of the competition.

The most respected conference on Viral Safety, tackling the latest technologies, regulations and methods being adopted to succesfully detect and remove unwanted viruses in biological and plasma-based production more

10% discount for SBA members.

Informa Life Sciences presents it's 8th International Congress on Recombinant Antibodies. This conference is the largest European event for antibody research and development. Day 1 will focus on advances in antibody engineering; Day 2 will build on this with the exploration of novel applications of antibodies and by Day 3 the focus will have shifted to recent advances in clinical developments including immunogenicity, oncology and autoimmune diseases. more

25% discount off full conference fee for SBA members.

IBC's Next Generation Protein Therapeutics Summit brings together four conferences - Beyond Antibodies, Protein Engineering & Design, Crossing the Barriers and Immunogenicity of Biologics - in one venue to discuss the emerging wave of proteins and biologics being explored for therapeutic potential. Novel scaffolds, new approaches to improve functionality of proteins and advances in protein engineering and design are opening up a wealth of opportunities for drug development. This summit will highlight numerous programs in preclinical and clinical development and explore solutions to some of the continuing challenges of biopharmaceutical drug development, including alternative protein delivery and immunogenicity. more

200$ discount for SBA members.

ChinaBio® LLC and EBD Group will host their first ChinaBio® Partnering Forum in Shanghai to meet the needs of biotech and pharma companies as well as developers of early stage technology looking for funding and strategic partnerships. This event brought together 486 attendees from over 270 companies located all over the world for two days of intense partnering. more

Le cours est ouvert aux gymnasiennes et gymnasiens/collégiennes et collégiens de toute la Suisse pour qui
l’examen de maturité est prévu pour l’année 2011 ou 2012.

L’Académie suisse des sciences naturelles (SCNAT) propose une introduction expérimentale dans le monde
de la génétique :

• extraire son propre ADN et l’analyser
• apprendre les manipulations génétiques de base
• modifier génétiquement des bactéries pour produire des protéines en grande quantité
• produire des algues transgéniques par transformation du chloroplaste avec un canon à gènes
• apprécier la réalité de la recherche en visitant des laboratoires à l’université

The 20th IUHPE World Conferences on Health Promotion – Geneva 2010 – is a triennial event organized by the International Union for Health Promotion and Education and Health Promotion Switzerland.

In a globalized world, the dynamics of modernisation and urbanisation pose major challenges to both health promotion and societal development. Therefore, the focus of the Geneva 2010 conference is on building bridges between health promotion and sustainable development by:

• presenting and discussing state-of-the-art knowledge and cross-cutting issues in health promotion and sustainable development,
• showcasing and challenging best practice in health promotion, with focus on sustainability, and
• initiating strong alliances and partnerships for promoting sound policies and practices that positively impact the health of people, societies and the planet.

Biocatalysis encompasses the use of enzymes or whole cell systems for effecting the conversion of readily available, inexpensive starting materials to high value products. Enzymes frequently display exquisite selectivity, particularly chemo-, enantio- and regioselectivity, making them attractive catalysts for a wide range of chemical transformations. Enzymes also typically operate under mild conditions of pH and temperature leading to the formation of products of high purity. Modern tools of protein discovery and engineering aid the development of novel biocatalysts and their tailor-designed implementation into industrial processes. Consequently, they find wide application in the production of pharmaceutical intermediates, fine chemicals, agrochemicals, novel materials, diagnostics, biofuels and performance chemicals. The Biocatalysis Gordon Conference highlights the best science, technologies and case studies responsible for the understanding, development and incorporation of biocatalysts around the world. more

The BioBusiness Asia Conference is launching its call for speakers for the 2010 conference. The Conference provides a platform bringing a variety of biotech thought leaders and industry experts together to explore hidden business opportunities and address issues pertaining to the biotechnology industry. This business model session will take place in the morning of July 21, 2010. more

25% discount off full conference fee for SBA members.

Drug Discovery & Development Week includes five targeted scientific conferences featuring practical strategies and forward-looking approaches to help attendees accelerate small molecules, antibody therapeutics and oligonucleotide therapeutics from early discovery to the clinic. Individual conferences allow attendees to meet face-to-face with colleagues across the entire life sciences R&D value chain including leading scientists, group leaders and executives who are seeking solutions for their specific drug discovery and development challenges. The exhibit hall will showcase cutting-edge technologies and innovative solutions to help you make better decisions and to support your scientific discoveries. more

The Third International NanoBio Conference will take place at ETH Zurich, August 24-27, 2010. For this 4-day conference, we will have at least 31 invited, internationally renowned speakers for plenary and two parallel sessions, as well as poster sessions and an industrial exhibition. We expect around 500 participants, 250 - 300 posters and about 15-20 exhibitors.

This meeting gathers the leaders of this progressive field from all over the world helping scientists to get an update on the most recent achievements in the different topics of nanobiotechnology, to discuss, to network, to exchange stimulating new ideas, and to take responsibility in forming public opinion about nanobiotechnology. more

This meeting, which will be supported by the Federal Ministry of Education and Research (BMBF) will provide an ideal forum for the exchange of information between specialists from both the academic and industrial sectors._We will take care of a stimulating and open scientific atmosphere to foster the development of new collaborations. Industrial Biotechnology, making use of enzymes and whole cells, will play a significant role in the sustainable development of future key technologies such as biorefineries. The major topics to be addressed are:

• Enzyme discovery, recombinant production, evolution and design
• Structure-function analysis and modelling
• Enzymatic and whole cell biotransformations
• Bioprocess engineering and downstream processing
• Biorefinery and sustainable development of industrial processes

25% discount off full conference fee for SBA members.

The inaugural BioProcess International™ China conference & exhibition 2009 was a resounding success. With almost 160 attendees over the 2 days, the event was abuzz with exciting presentations, engaged conversations, and captive audiences. Most attendees come from China, with about 25% from international/regional countries including Japan, India, Korea, Taiwan, US etc.

As a first event of its kind in China, the conference covers a wide spectrum of technical topics that introduce attendees to the whole value chain of bioprocessing, including cell line engineering & development, cell culture, analytical characterization, analytical methods development, purification & recovery, technology transfer and single use technologies. The Plenary Sessions, meanwhile, discusses trends and developments in 3 main areas - novel biotherapeutics, biosimilars and vaccines. more

Join us at the 14th International Biotechnology Symposium, Rimini, Italy, 15-19 September 2010, to explore the frontiers and applications of biotechnology for a healthier, more sustainable future and a knowledge-based bioeconomy.

A large participation of the international biotech industry, a dynamic and RTD-oriented program, highly qualified speakers from academia, governmental institutions, and industry will be some of the major features of IBS2010.We hope that you will join us. more

Five years on, it’s time to evaluate progress, to learn from past experiences and to collect input for a European vision on the future of KBBE. With this in mind, the Flemish department of Economy, Science and Innovation (EWI) organises an international conference on the 14th September of 2010 as a priority defined under the objectives of the Belgian Presidency of the European Union Council[1]. The event will be attended by policy makers, renowned academics and representatives from the industry and will include presentations from several high level speakers including Flemish Ministers and European Commissioners.

By organising the conference, EWI aims to offer a valuable opportunity for the Biotech sector to raise awareness of its potential to provide solutions to the many challenges Europeans will be facing in the following decades. Your organisation, as an integral part of the sector, will have the occasion to showcase the societal benefits of your products to a high-level audience of approximately 500 leading academics, decision makers, regulators and industry colleagues. more

200$ discount for SBA members.

BioPharm America™ is where biotech industry partnerships get started. Meet face-to-face with biotech and pharma executives from around the world to identify and enter strategic relationships. Equipped with partneringONE™, the world’s leading web-based partnering system for the life science industry, BioPharm America is the only event in North America based on the same reputable formula as EBD Group’s acclaimed European events BIO-Europe and BIO-Europe Spring®. more

25% discount off full conference fee for SBA members.

• Strategies to optimize capacity utilization and mitigate risk
• Proven approaches to improve product lifecycle management and minimize risk
• Novel methods to accelerate development and enhance manufacturability
• Alternative techniques and technologies to de-bottleneck downstream processing

The life science industry continues to offer significant potential for growth. For this reason and despite the economic crisis, it is definitely "all systems go" for ILMAC 2010, which will be held from 21 to 24 September 2010 in Basel. According to exhibition manager Robert Appel, now is the right time to start planning your exhibition presence.

Any companies which are currently planning their attendance at ILMAC are definitely making the right decision. Exhibitions, and ILMAC in particular, remain the most efficient way of making valuable contacts and effectively presenting new products to a broader industry audience.
more

MipTec is the premier European conference and exhibition encompassing innovative approaches to high quality science and technology for efficient drug discovery. The mission of MipTec is to bring together scientists from all disciplines involved in drug discovery within pharmaceutical and biotech companies, academic labs and technology providers in an atmosphere where ideas and experiences are shared and discussed. This atmosphere is created through a scientific program covering key topics and the latest breakthroughs in the diverse fields that make up drug discovery. more

25% discount off full conference fee for SBA members.

For its tenth year, IBCs three-day Formulation Strategies for Protein Therapeutics conference presented a unique combination of cutting edge science, best practices and responses to regulatory challenges.

Formulation Strategies is co-located with the BioProcess International Conference and Exhibition, offering delegates the opportunity to visit with 150 suppliers of bioprocess technology and services and network with industry scientists and engineers. more

The objective of DC2010 is to foster vaccine research and its translation into preventive and therapeutic vaccines in infectious and autoimmune diseases, cancer, and transplantation. The Symposium will feature Plenary Sessions with lectures by leaders in the field and Forum Sessions for poster presentations, discussion and sharing ideas. Questions about the applications of Dendritic Cells will be the organizing principle of the Forum. more

Biotechnology represents vital technological innovation that can solve a myriad of problems confronting humankind today- problems in such areas as energy, the environment, food, medicine, and telecommunications.

BioJapan promises to be even bigger and better than this year's event. We hope you join and experience lively activities of regeneration of bioindustry at BioJapan2010 in Yokohama.
more

BIOSPAIN 2010 is the International Meeting on Biotechnology to be held in Pamplona from the 29th of September to the 1st of October 2010. Since it´s first edition, launched back in the year 2003, it has becomeone of the leading biotechnology events in Europe.

BIOSPAIN 2010 will feature a trade exhibition, partnering event, investment fórum, scientific congress, top level seminars & conferences and a career fair with a well-balanced mixture of local and international private companies, universities, overseas clusters, research institutes and governmental bodies.

The past edition, held in Granada in September 2008, attracted over 1.100 visitors/daily from 26 countries and displayed over 140 exhibitors. BIOSPAIN 2010 expects to increase substantially this figures!

ASEBIO and Swiss Biotech Association have signed a Memorandum of Understanding on November 3, 2009. more

15% discount on full conference fee for SBA members.

The World Vaccine Congress Lyon is where pharmaceutical companies, biotechs, healthcare firms and investors to discuss future strategy and opportunity within the industry.

• 4 full days of content
• 80 of the highest calibre speakers and ministers
• over 275 attendees

Join the Swiss Pavilion organized by OSEC

BIOTECHNICA is Europe's leading annual event for biotechnology and the life sciences. It covers the entire spectrum of biotechnology, including fundamentals and equipment, bio-informatics and services, and addresses all five major fields of application, i.e. pharma­ceuticals/medicine, industrial manufacturing, food, agriculture and the environment.

Ever since 1985, BIOTECHNICA has been organized and staged by Deutsche Messe AG in Hannover, Germany. more

Was erwartet ein Journalist von mir? Wie formuliere ich meine Botschaft? Wie bereite ich mich auf ein Interview vor? Habe ich das Recht, den Artikel vor der Publikation zu lesen?

Im Umgang mit Journalisten gelten ganz bestimmte Spielregeln. Wer mit diesen vertraut ist, dem wird es leichter fallen, mit den Medien zu sprechen und sich so in der Öffentlichkeit Gehör zu verschaffen.
more

200 Euro discount for SBA members.

BIO-Europe is Europe's largest partnering conference, serving the global biotechnology industry. The conference annually attracts leading dealmakers from biotech, pharma and finance along with the most exciting emerging companies. Produced with the support of BIO, it is regarded as a “must attend” event for the biotech industry.
BIO-Europe plays host to top executives from:

• Biotech companies
• Large and midsize pharmaceutical companies
• Financial groups
• Other industry related service companies

15% discount on full conference fee for SBA members.

The 6th annual European Antibody Congress is the Antibody industry's number one congress for addressing the R&D, commercial application and manufacture of antibodies across the whole therapeutic landscape.

• 3 full days of content
• 50+ speakers of the highest calibre
• over 300 attendees
• » request a sponsorship prospect

15% discount on full conference fee for SBA members.

World Influenza Congress Europe is the annual vaccine conference for influenza candidate commercialisation, revenue generation and market supply.  It also highlights policy and planning, influenza research & development, and stakeholder partnerships.

As an addition to an already globally recognised World Vaccine Congress series, World Influenza Congress Europe is positioned as Europe's largest and most influential Influenza vaccine COMMERCIALISATION event. more